In 2009, director Alex Gibney embarked on a mission to create The Road Back, a documentary that focused on cyclist Lance Armstrong and his comeback during a pivotal year following a four-year hiatus from the sport. However, three years later, a doping investigation led to a shocking revelation in October 2012: Armstrong faced a lifetime ban from competition, and all seven of his esteemed Tour de France titles were stripped away, forcing the documentary to be shelved indefinitely. It wasn't until January 14, 2013, just hours after his highly publicized interview with Oprah Winfrey, that Armstrong returned to Gibney to clarify the misconceptions surrounding his illustrious yet tumultuous career.
Armstrong's journey began much earlier, marked by a devastating cancer diagnosis that forced him to step away from professional cycling. Before his illness, he had firmly established himself as a dominant force, winning the prestigious Tour de France seven times, all while facing persistent doping allegations that haunted him throughout his career. By 2012, these accusations had permeated mainstream media to the point where Armstrong could no longer keep his defenses intact. Several of his former teammates came forward to testify against him, asserting they had witnessed his drug use firsthand. Consequently, the UCI (Union Cycliste Internationale) banned him from cycling and retroactively stripped him of his titles in October 2012, setting the stage for his notorious Oprah interview in January 2013. During this candid admission, Lance confessed to using performance-enhancing drugs throughout each of his Tour de France victories and regretted his return to cycling in 2009, a comeback that ultimately contributed to his fall from grace.
The implications of Armstrong’s actions were compounded by the UCI's long-held belief that he had cheated throughout his career. A French article titled The Armstrong Lie highlighted the alarming discovery that his urine samples from his first Tour de France win in 1999 contained EPO, a banned performance enhancer. Interestingly, the UCI permitted Armstrong to compete in the Tour de France in 2009, despite evidence suggesting misconduct. In 2006, a significant doping crackdown implicated 58 cyclists, including each of those who had shared the podium with Armstrong from 1999 to 2005, yet he escaped scrutiny due to his retirement the previous year.
Before making his mark on the cycling world, Lance Armstrong faced a daunting battle with testicular cancer that had spread aggressively by 1999. His fight for survival included an experimental procedure at UCLA involving the removal of a testicle, brain surgery, and grueling chemotherapy treatments. Against seemingly insurmountable odds, Lance not only survived but sought to reclaim his former glory by winning the Tour de France as a testament to his enduring spirit. His 1999 victory was particularly astonishing for a cyclist who was not previously recognized as a climber, demonstrating immense speed and power that defied expectations, especially as a cancer survivor.
However, Armstrong's journey was not without controversy. A cortisone drug appeared in his urine during the 1999 race, prompting inquiries from the UCI. To evade potential repercussions, Lance's team found a commercial brand that substantiated his use of cortisone as a remedy for a skin rash, thereby diffusing the situation at that time. Central to Armstrong's doping narrative was Michele Ferrari, his team doctor, infamous for administering performance-enhancing drugs to athletes. Having known Armstrong since 1995, Ferrari devised strategies that included switching to lower gears on mountainous terrain to lessen muscle strain while introducing drugs to increase oxygen levels in the blood, enabling endurance over extended periods. Additionally, Ferrari's connections with UCI's drug testing labs helped ensure Armstrong's drug use remained below the detection threshold. Despite Ferrari’s eventual conviction for sports fraud in 2004, Armstrong persisted in publicly distancing himself from him.
In 2013, Armstrong remarked that EPO doping had gained traction in Europe during the 1980s and 1990s, necessitating his adoption of its use to remain competitive from 1995 onward, a time when EPO was undetectable in urine tests. As testing methods advanced, Ferrari encouraged Armstrong to take part in blood transfusions—removing blood prior to a race and reintroducing it just before—thereby boosting red blood cell count without leaving traces.
In 2008, Armstrong aimed for a commendable return to cycling, determined to win the Tour de France and silence his critics regarding the legitimacy of his seven titles. However, complications arose when a former teammate, previously implicated in doping in 2006, sought a position on his team but was turned away in efforts to portray a "clean team." This former teammate was privy to the extent of Lance's drug usage and ultimately played a role in his downfall. As the 2009 Tour de France commenced, while initially positioned 10th after stage 1, Armstrong climbed quickly to second place by stage 2. The narrative also introduces a former teammate, Frankie, now a sports reporter, with whom Lance maintained a fragile connection during this period. After having testified against Armstrong in 2006 alongside his wife, the couple found themselves ostracized from the cycling community. Betsy, Frankie's wife, became increasingly obsessed with exposing Armstrong’s deceit, ultimately rallying support from other former teammates, forming a coalition against him.
As the investigation deepened, Lance's legal team retaliated with extensive lawsuits against his accusers, often using financial leverage to intimidate them into silence. Critics also alleged that UCI's president, Verbruggen, was complicit in protecting Armstrong, hinting at a mutual financial interest in sustaining his image as a champion of the sport. By stage 15 of the 2009 race, Lance found himself 42 seconds behind Contador, who wore the yellow jersey. Despite his relentless efforts, he finished third, leading him to contemplate the integrity of his clean race in 2009 as validation for his previous accomplishments. However, subsequent investigations raised new doubts regarding potential blood transfusion use during that very race.
Ultimately, the revelations from the 2009 Tour ignited a torrent of testimonies from critics fueled by a desire to clarify the reality of Armstrong's earlier races, demolishing the facade he had constructed. The burden of truth became too heavy to maintain, paving the way for the explosive Oprah interview in 2013. Following these astonishing admissions, Lance Armstrong faced a lawsuit from the US Postal Service, his sponsor during his iconic wins, for a staggering $100 million, and was subsequently banned from all sports for life by the World Anti-Doping Agency.
